-
Something wrong with this record ?
Involvement of growth factors in molecular effects of ibuprofen in dental pulp stem cells
Adamičková Adriana, Adamička Matúš, Gažová Andrea, Kyselovič Ján
Language English Country Czech Republic
- MeSH
- Anti-Inflammatory Agents, Non-Steroidal pharmacology MeSH
- Gene Expression MeSH
- Hepatocyte Growth Factor MeSH
- Ibuprofen * therapeutic use MeSH
- Stem Cells MeSH
- Skull pathology MeSH
- Humans MeSH
- Mesenchymal Stem Cells * MeSH
- Bone Diseases drug therapy therapy MeSH
- Paracrine Communication MeSH
- Polymerase Chain Reaction MeSH
- Regenerative Medicine methods MeSH
- In Vitro Techniques methods MeSH
- Vascular Endothelial Growth Factor A MeSH
- Check Tag
- Humans MeSH
Stem cells represent promising candidates for regenerative therapy of craniomaxillofacial bone defects, where common techniques, such as autogenous bone graft, allografts or others possess shortcomings and limitations in restoring the morphology and function in bone loss. The efficacy of regenerative therapy with mesenchymal stromal cells (MSC) depends on a combination of the interactions between transplanted MSCs and cellular and molecular components of the recipient, and any current pharmacotherapy in the recipient with effects on transplanted MSC and the bone microenvironment. In the present investigation, dental pulp stem cells (DPSC) were isolated from human impacted third molar teeth. DPSC were treated with ibuprofen in vitro at clinically relevant concentration and relative expression of selected genes were assessed. Our preliminary data suggest a significant effect of ibuprofen as indicated by upregulation of the relative expression levels of growth factors, vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF). While the effects of stem cell therapy in bone regeneration are being investigated in ongoing clinical trials, the effects of commonly used pharmacotherapy should be studied for its potential impact on the paracrine effects of stem cells and consequently bone regenerative processes.
5th Department of Internal Medicine Faculty of Medicine Comenius University Bratislava
University Hospital Bratislava Hospital Ružinov Bratislava Slovakia
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22022121
- 003
- CZ-PrNML
- 005
- 20250617140131.0
- 007
- ta
- 008
- 220919s2022 xr d f 000 0|eng||
- 009
- AR
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Samáková, Adriana, $d 1993- $7 xx0267319 $u 5th Department of Internal Medicine, Faculty of Medicine, Comenius University Bratislava; University Hospital, Bratislava – Hospital Ružinov, Bratislava, Slovakia
- 245 10
- $a Involvement of growth factors in molecular effects of ibuprofen in dental pulp stem cells / $c Adamičková Adriana, Adamička Matúš, Gažová Andrea, Kyselovič Ján
- 504 __
- $a Literatura
- 520 9_
- $a Stem cells represent promising candidates for regenerative therapy of craniomaxillofacial bone defects, where common techniques, such as autogenous bone graft, allografts or others possess shortcomings and limitations in restoring the morphology and function in bone loss. The efficacy of regenerative therapy with mesenchymal stromal cells (MSC) depends on a combination of the interactions between transplanted MSCs and cellular and molecular components of the recipient, and any current pharmacotherapy in the recipient with effects on transplanted MSC and the bone microenvironment. In the present investigation, dental pulp stem cells (DPSC) were isolated from human impacted third molar teeth. DPSC were treated with ibuprofen in vitro at clinically relevant concentration and relative expression of selected genes were assessed. Our preliminary data suggest a significant effect of ibuprofen as indicated by upregulation of the relative expression levels of growth factors, vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF). While the effects of stem cell therapy in bone regeneration are being investigated in ongoing clinical trials, the effects of commonly used pharmacotherapy should be studied for its potential impact on the paracrine effects of stem cells and consequently bone regenerative processes.
- 650 _7
- $a lidé $7 D006801 $2 czmesh
- 650 17
- $a ibuprofen $x terapeutické užití $7 D007052 $2 czmesh
- 650 17
- $a mezenchymální kmenové buňky $7 D059630 $2 czmesh
- 650 _7
- $a kmenové buňky $7 D013234 $2 czmesh
- 650 _7
- $a nemoci kostí $x farmakoterapie $x terapie $7 D001847 $2 czmesh
- 650 _7
- $a lebka $x patologie $7 D012886 $2 czmesh
- 650 _7
- $a exprese genu $7 D015870 $2 czmesh
- 650 _7
- $a vaskulární endoteliální růstový faktor A $7 D042461 $2 czmesh
- 650 _7
- $a hepatocytární růstový faktor $7 D017228 $2 czmesh
- 650 _7
- $a regenerativní lékařství $x metody $7 D044968 $2 czmesh
- 650 _7
- $a parakrinní signalizace $7 D019899 $2 czmesh
- 650 _7
- $a antiflogistika nesteroidní $x farmakologie $7 D000894 $2 czmesh
- 650 _7
- $a polymerázová řetězová reakce $7 D016133 $2 czmesh
- 650 _7
- $a techniky in vitro $x metody $7 D066298 $2 czmesh
- 700 1_
- $a Adamička, Matúš $7 xx0333142 $u Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University Bratislava, Slovakia
- 700 1_
- $a Gažová, Andrea, $d 1980- $7 xx0255822 $u Institute of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Comenius University Bratislava, Slovakia
- 700 1_
- $a Kyselovič, Ján, $d 1963- $7 xx0082943 $u 5th Department of Internal Medicine, Faculty of Medicine, Comenius University Bratislava; University Hospital, Bratislava – Hospital Ružinov, Bratislava, Slovakia; Department of Pharmacology and Toxicology, University of Veterinary Medicine and Pharmacy in Košice, Slovakia
- 773 0_
- $t Clinical osteology $x 2571-1326 $g Roč. 27, č. 1 (2022), s. 26-29 $w MED00197385
- 856 41
- $u https://www.prolekare.cz/casopisy/clinical-osteology/2022-1-24/involvement-of-growth-factors-in-molecular-effects-of-ibuprofen-in-dental-pulp-stem-cells-130733 $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2839 $c 474 b $y p $z 0
- 990 __
- $a 20220919104527 $b ABA008
- 991 __
- $a 20250617140123 $b ABA008
- 999 __
- $a ok $b bmc $g 1839275 $s 1173391
- BAS __
- $a 3
- BMC __
- $a 2022 $b 27 $c 1 $d 26-29 $i 2571-1326 $m Clinical Osteology $x MED00197385
- LZP __
- $c NLK189 $d 20221016 $a NLK 2022-33/dk